Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.63, $0.16 better than the analyst estimate of $0.47. Revenue for the quarter came in at $267.5 million versus the consensus estimate of $275.81 million.

GUIDANCE:

Dolby Laboratories sees Q3 2017 EPS of $0.75-$0.81, versus the consensus of $0.64. Dolby Laboratories sees Q3 2017 revenue of $290-305 million, versus the consensus of $293.3 million.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.